The global clinical decision support system market (CDSS) is anticipated to grow at 6.5% CAGR owing to the initiatives by the government to promote the adoption of HIT solutions, rising adoption of CDSS-enabled EHRs, a mounting number of collaborations and partnerships between the industry players, rising incidences of medication errors, increased prevalence of mHealth and big data analytics. Moreover, the increased need to develop the quality of care and rapid enhancement in the field of biotechnology and bioinformatics will lead to expansion and optimizing the data storage, administration, and analytics platforms, resulting in the growth of the global CDSS market.

The COVID-19 pandemic has had a positive impact o the global clinical decision support system (CDSS) market owing to increased demand for precise diagnosis and treatment devices in various countries globally. CDSS is beneficial as it offers healthcare providers to monitor the patients via digitally connected non-invasive devices like pulse oximeters, home BP monitors. Moreover, the increased demand for remote patient monitoring and telehealth solutions will bolster the growth of the CDSS market

Request to get a frees ample copy at https://www.vynzresearch.com/healthcare/cdss-market/request-sample

Based on the model, the knowledge-based CDSS dominates the market and is anticipated to have a high CAGR over the projected period owing to the various advantages in relation to its functionalities offered like aiding clinicians with knowledge-based reasoning to make clinical decisions during uncertainties. A knowledge-based CDSS system can be integrated into clinical workflows and produces fewer errors as compared to non-knowledge-based CDSS.

North America dominates the CDSS market owing to the increased demand for healthcare information technology in the healthcare sector, robust technological development, and increased focus on quality healthcare services that will propel the growth in the region.

In 2020, IBM Watson Health and EBSCO Information Services had a strategic collaboration and launched Integrated Clinical Decision Support Solution The companies are merging their respective solution suites into a single, high-value global solution called DynaMed and Micromedex With Watson that will bring together drug and disease content into a single source for evidence-based insights and help in making clinical decisions.

The prominent players in the CDSS industry include Cerner Corporation, Epic Systems Corporation, Medical Information Technology, Inc., Wolter Kluwer N.V., Zynx Health Incorporated, Elsevier, IBM Watson Health, Allscripts Healthcare, LLC, Siemens Healthcare GmbH, and McKesson Corporation.

Source: VynZ Research